Home » Newsletters » BioWorld

BioWorld

Sep. 8, 2000

View Archived Issues

Pharmos Raises $11M Privately To Fund Dexanabinol Program

Other News To Note

PowderJect Getting Into Vaccines Through Celltech Unit Acquisition

Albany Molecular Seeks $105M Through Offering Of 3M Shares

NPS Seeks $127M For Lead Programs Via Public Offering

Unique Transgenic Mice Modeling Myotonic Dystrophy Defy Genetic Dogma Governing RNA's Day Job

Geron Enters $50M Financing Facility With Acqua Wellington

HGS Files $1B Shelf Facility, Adds Flexibility To Position

Genzyme Plans BLA Based On Transgenic Compound Results